Wylre 1, Netherlands

Veikko Tarrkkanen

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Veikko Tarrkkanen. Retrieved from https://idiyas.com/inventor/veikko-tarrkkanen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Veikko Tarrkkanen: Innovator in Bioluminescence Assays

Introduction

Veikko Tarrkkanen is a notable inventor based in Wylre, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the quantitative measurement of digoxin and other digitaloids.

Latest Patents

Tarrkkanen holds a patent for a method titled "Assaying of digoxin by means of bioluminescence and inhibition of Na.sup.+." This innovative method allows for the quantitative measurement of digoxin in serum by utilizing the inhibition of Na.sup+, K.sup+-specific ATPase enzyme. The method is based on the receptor binding principle and employs a firefly luciferin-luciferase bioluminescence assay for measurement. It offers similar sensitivity to traditional radioimmunoassays but is simpler and can be performed with low-cost instrumentation. He has 1 patent to his name.

Career Highlights

Throughout his career, Tarrkkanen has focused on developing methods that enhance the accuracy and efficiency of biochemical assays. His work has been instrumental in advancing the field and providing alternatives to more complex and expensive testing methods.

Collaborations

Tarrkkanen has collaborated with Seppo Kolehmainen, contributing to the development of innovative solutions in their field.

Conclusion

Veikko Tarrkkanen's contributions to bioluminescence assays represent a significant advancement in the measurement of digoxin and digitaloids. His innovative approach simplifies the testing process while maintaining accuracy, showcasing his impact on the field of biochemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…